1. Introduction {#sec1}
===============

Although relatively infrequent, congenital intracranial vascular malformations (IVMs) represent an important cause of intracranial hemorrhage with potentially devastating consequences for the patient \[[@B1], [@B2]\]. Brain arteriovenous malformations (BAVMs) and cavernous malformations (CMs) are the most important forms among IVMs. The detection rate of BAVMs ranges between 1.1--1.4/100,000 person-years and is approximately 2.2/100,000 person-years for all other forms of IVMs, including CM, venous malformation (VM), vein of Galen malformation, and dural AV fistula, respectively \[[@B2]--[@B4]\].

Current management of IVMs is an interdisciplinary challenge, involving neurosurgery, interventional neuroradiology, radiation therapy, and neurology. The potentially deleterious effects of IVM-related intracranial hemorrhage (ICrH) and the risk of recurrent bleeds led to the current paradigm of obliterating the lesion, if deemed feasible with surgery, which appears logical and cause driven \[[@B5]--[@B7]\]. In contrast, some large case series found that most patients faired relatively well after the initial hemorrhage from ruptured BAVMs when compared to other causes of ICrH \[[@B8]--[@B11]\]. An ongoing multi center clinical trial, ARUBA, will compare the clinical outcome in patients with unruptured BAVMs randomized either into surgical interventional treatment or medical observation (natural history) \[[@B12], [@B13]\].

Currently, the management patterns vary across centers and may include patients with and without symptoms, with or without intracranial hemorrhage, and with incidentally found IVMs \[[@B5]\]. Specifically, BAVMs often undergo pre-surgical embolization in an attempt to devascularize the lesion for safer definitive surgery \[[@B6], [@B14]\]. Radiation therapy is another adjunct treatment form and also a sole option for lesions that are otherwise not accessible \[[@B14], [@B15]\]. Adding to the complexity of the procedures and the overall risk, multiple treatment sessions may be necessary and a small rate of recurrence after angiographically confirmed complete removal has been reported \[[@B16]\]. The goals of the present study are to determine the detection rate of IVMs, to assess patient and clinical characteristics, and to analyze treatment pattern and outcome in patients with IVMs admitted to US hospitals. In addition, a trend analysis is performed on above parameters and on hospital cost using nationwide data from year 2000 to 2007.

2. Methods {#sec2}
==========

The Nationwide Inpatient Sample (NIS) is part of the Healthcare Cost and Utilization Project (HCUP) which is sponsored by the Agency for Healthcare Research and Quality (AHRQ) of the US Department of Health & Human Services and represents the largest all-payer inpatient care database in the USA \[[@B17]\]. Datasets from year 2000 to 2007 were analyzed that included 7.4--8.0 million hospital admissions per year from 28 to 40 states and 994--1,044 nonfederal hospitals, respectively. This constitutes a 20% representative and stratified sample of US hospitals. The NIS contains only deidentified data.

Variables included demographic parameters, admission type, length of stay, discharge disposition, death, hospital location, and charges. In addition, relevant diagnoses and procedures in the database were identified using the ICD-9-CM system (The International Classification of Diseases, 9th Revision, Clinical Modification): adult patients (≥18 years) with IVM were selected using code 747.81 ([Figure 1](#fig1){ref-type="fig"}). Intracranial hemorrhages were identified using codes 430, 431, and 432.x, seizure using code 345.xx, and headache with 346.xx and 784.0, unruptured cerebral aneurysms with 437.3, and acute ischemic stroke with 433.xx and 434.xx, respectively. Procedures were selected using codes 88.41 (cerebral angiogram), 39.72 and 39.79 (embolization), 01.59 (surgery), 92.3x (radiosurgery), 39.5x (aneurysm clipping), and 96.7x (mechanical ventilation). The NIS collects up to 15 diagnoses and procedures for each admission. Thus, relevant modes of presentation, including intracranial hemorrhage, seizure, and headache were identified by selecting primary diagnoses only in addition to diagnoses found at "ANY" rank.

Analyses were weighted with provided discharge weight data that are used to create national estimates. For the trend analysis data were stratified into four two-year blocks. Univariate analyses included frequency (absolute number and %) and average values (SD; standard deviation) with respective comparative analyses (*χ*^2^-test, *t*-test for independent samples). In multivariate logistic regression models, the risk (odds ratio and 95% confidence interval; OR 95%-CI) of death and unfavorable discharge outcome (death or discharge, other than routine or to short-term hospital) was determined with input of significant and relevant variables from the univariate analysis. In addition, outcome was assessed for patients presenting with hemorrhage versus without. Outcome was further stratified into one group undergoing surgery and the other without surgery. Furthermore, factors were determined that were associated with hospital charges in multivariate linear regression models. A statistical test was considered significant when *P* \< 0.05. All statistics were calculated with SPSS 15.0 (Chicago, IL).

3. Results {#sec3}
==========

3.1. Detection Rate {#sec3.1}
-------------------

In the years from 2000 to 2007 a total of 58,051 admissions included the diagnosis of an IVM ([Table 1](#tab1){ref-type="table"}). This is approximately 0.02% of all admission (total number of admissions *n* = 306,447,670) and results in an annual hospital detection rate of approximately 2.4 IVM patients per 100,000 person-years in the US (average USA population 300 Million).

3.2. Patient Characteristics and Clinical Variables {#sec3.2}
---------------------------------------------------

Most admissions were acute admissions (63%) ([Table 1](#tab1){ref-type="table"}). In average the primary diagnosis was ICrH in 11%, headache, seizure, or cerebral ischemia in 13%, IVM in 46%, and 31% had other primary diagnoses. However, 28,760 (35%) patients had none of the typical "symptoms," including ICrH, seizure, headache, or cerebral ischemia.

3.3. Procedures and Outcome {#sec3.3}
---------------------------

The most frequent procedure was cerebral angiogram with 37%, followed by embolization and surgery with 13% in each category ([Table 1](#tab1){ref-type="table"}). In 72% none of above procedures was performed. Mechanical ventilation was necessary in 6% of the admissions. The average length of stay was  6 ± 8  days. In-hospital death occurred in 2% of the patients and unfavorable outcome, including death and outcome other than routine or short-term hospital, was observed in 20%.

3.4. Risk of Death and Unfavorable Outcome {#sec3.4}
------------------------------------------

A total of 19 variables were studied for their association with outcome in IVM patients ([Table 2](#tab2){ref-type="table"}). The variables were chosen based on statistical significance in the univariate analysis and based on their potential relevance in having an effect on outcome. Overall, mechanical ventilation (OR 20.3 \[95%-CI 15.0--27.3\]) and ICrH (OR 2.9 \[2.3--3.8\]) were strongly associated with in-hospital death ([Table 2](#tab2){ref-type="table"}). Unfavorable discharge outcome showed strong positive associations with ventilation (OR 2.8 \[2.4--3.2\]), ICrH (OR 2.1 \[1.8--2.3\]), seizure (OR 1.6 \[1.5--1.7\]), acute ischemic stroke (OR 1.5 \[1.4--1.8\]), surgery (OR 1.4 \[1.2--1.6\]), and unruptured ICA-aneurysm (OR 1.4 \[1.1--1.7\]).

3.5. Hemorrhagic Presentation and Surgery {#sec3.5}
-----------------------------------------

### 3.5.1. Hemorrhagic versus Nonhemorrhagic Presentation {#sec3.5.1}

Compared with patients with ICrH, patients without bleeds were younger, more frequently women and White, were more often elective admissions, and presented more often with ischemia, seizure, or headache, underwent more endovascular and radiosurgical interventions, and had a shorter length of stay and better outcomes ([Table 3](#tab3){ref-type="table"}/Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}).

### 3.5.2. Hemorrhagic Presentation: Surgery versus No Surgery {#sec3.5.2}

From 6,144 patients with ICrH 12.1% (*n* = 745) underwent surgery. Compared with patient who did not undergo surgery, patients with surgery were less frequently White, but more often Asian, more often elective admissions, had more parenchymal bleeds and ischemia, longer length of stay, and worse outcomes ([Table 3](#tab3){ref-type="table"}/Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}).

### 3.5.3. Nonhemorrhagic Presentation: Surgery versus No Surgery {#sec3.5.3}

From 51,873 patients without ICrH 13.1% (*n* = 6, 697) underwent surgery. Compared with patient who did not undergo surgery, patients with surgery were younger, less frequently White or Black, but more often Hispanic, more often elective admissions, had less frequently ischemia or headache, endovascular treatment or radiosurgery, but underwent more often aneurysm clipping, had longer length of stay, and worse outcomes ([Table 3](#tab3){ref-type="table"}/Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}).

3.6. Cost {#sec3.6}
---------

Hospital charges ([Figure 3](#fig3){ref-type="fig"}) increased from an average charge of \$32,355 ± 43,442 per admission in 2000/2001 to an average of \$51,398 ± 16412 in 2006/2007. The total charge increased from \$415,876,303 in 2000/2001 to \$843,533,680 in 2006/2007 during this period. This equals an absolute increase of \$427,657,377 and a relative increase by 103%.

A total of 23 variables were included to determine the association with hospital charges ([Table 4](#tab4){ref-type="table"}). Major determinants included length of stay, number of procedures, embolization, and surgery (*r*^2^ = 0.66; *P* \< 0.001). In a second model only 8 variables were included that revealed similar results as the first model, but included "time" as a major determinant (*r*^2^ = 0.62; *P* \< 0.001). The overall cost-to-charge ratio was 0.5.

3.7. Trend Analysis {#sec3.7}
-------------------

Over time there was an increase in the number of IVM-related admissions, average age, proportion of women, proportion of acute admissions, and number of diagnoses per patient. Frequencies of cerebral ischemia (stroke and TIA) and headache increased, whereas the incidence of ICrH and seizure showed a downward trend. Except for embolization, all other operative procedures were performed less frequently over time. Although in-hospital death rate remained stable, the proportion of unfavorable discharge outcome increased over time.

3.8. Comparison with Population Estimates {#sec3.8}
-----------------------------------------

Data from the US Census 2000 showed similar population distribution pattern compared with the NIS IVM sample: North-East 18.3% (versus 19.1%), Midwest 22.1% (versus 22.2%), South 36.4 (versus 34%), and West 23.2% (24.7). The distribution of rural, urban, and urban academic centers were similar across all four US regions ([Figure 4](#fig4){ref-type="fig"}). The racial-ethnic distributions in the NIS IVM-sample match the data from the US Census 2000 ([Figure 5](#fig5){ref-type="fig"}).

4. Discussion {#sec4}
=============

4.1. Epidemiology and Clinical Features {#sec4.1}
---------------------------------------

Based on the average frequency of ICrH of 11% as the primary diagnosis and assuming 50--62% of adult BAVM patients present without hemorrhage initially \[[@B3], [@B11]\], the crude estimate of "incidental" BAVMs would be approximately 22--27% of the NIS IVM sample, that is, approximately 1600--2000 patients per year. With consideration of multiple admissions---the NIS does not allow the identification of multiple admissions---BAVM-related admissions may be much higher. Among other IVMs than AVMs, cerebral CMs and VMs (often associated with each other) are more frequent, but relatively benign diseases that may present with signs of new or old hemorrhage previously left undetected due to lacking symptoms \[[@B18], [@B19]\]. Vein of Galen malformations are prevalent in childhood and AV fistula mostly present without a bleed \[[@B20]\].

The ICD-9 coding system is not specific in terms of type of congenital cerebrovascular malformation. Thus, the estimate on the incidence and prevalence of IVM subtypes can only be crude. However, our estimate on the average annual detection rate of 2.24 IVMs per 100,000 patient-years is similar to findings from previous population-based studies, such as from Olmsted County in Minnesota \[[@B21]\] and the New York Islands \[[@B3]\], USA, and Scotland \[[@B2]\], UK. Hereby, detection rates for BAVMs range from 1.11--1.34 per 100,000 person-years, for CMs from 0.17--0.57 per 100,000 person-years, for VMs from 0.41--0.44 per 100,000 person-years, for dural AVMs from 0.15-0.16 per 100,000 person-years, and for all IVMs from 1.82--2.3 per 100,000 person-years.

With increasing utilization of brain imaging, such as CT and MRI, more IVMs are found incidentally than before \[[@B3], [@B19]\]. However, symptoms, including seizure, headache, focal and global neurological deficits, and tinnitus, among others, account for the detection of a significant proportion of BAVMs (79--85%), CMs (40--43%), VMs (7--14%), and dural AV fistulas (85--100%) \[[@B2], [@B21]\]. Prospective studies found that patients with BAVMs presented with ICrH, seizure, headache, and focal neurological deficits in 38--71%, 24--40%, 5--14%, and 5--20%, respectively \[[@B22]--[@B25]\]. When our findings on the frequency of ICrH (11%), seizure (6%), headache (2%), and cerebral ischemia (5%) are translated into relative proportions, they result in 46%, 25%, 8%, and 21%, respectively.

4.2. Treatment and Outcome {#sec4.2}
--------------------------

The multivariate analyses showed that mechanical ventilation had the highest association with death or unfavorable outcome. A plausible way of interpretation is that ICrH and surgery, both with negative associations with outcome, would necessitate intensive medical care like for any patient in a critical condition. However, seizure, ischemic stroke, and unruptured aneurysm were also significantly associated with unfavorable outcome some of which might occur concurrently with hemorrhage, but may also be unrelated to it.

The clinical outcome after BAVM-related hemorrhage appears to be more favorable compared with the outcome after primary intracerebral hemorrhage (ICH) \[[@B8], [@B9]\]. Death rates following BAVM-related bleeds range between 0--11% (versus 50% after ICH) and short- (30 days) and medium-term (one year) functional outcome has been observed to be relatively favorable with a median NIHSS score of 1 (versus median NIHSS of 12) and median Rankin Scale (RS) score of 2 (versus median RS of 6), respectively.

Because of the negative associations with outcome and because it is difficult to tell which IVM subtype was treated in our sample, we performed a more thorough analysis based on the presence of ICrH (primary diagnosis) and on whether surgery was performed or not. Overall, 9% of the patients with ICrH died and 42% had unfavorable discharge outcome. Among patients without hemorrhage 0.9% died and 17% had unfavorable outcome. The odds for death and bad outcome were highest with the presence of ICrH. Interestingly, surgery was linked to higher odds for death in patients with bleeds and to higher odds for bad outcome in both, bled and unbled patients. Whether this indicates that the most severely affected patients and challenging IVMs are selected for surgery or whether surgery itself poses a greater risk to the patient, regardless of the integrity of the IVM, cannot be derived from our data. This may simply reflect the fact that surgery has a known complication and risk profile that may be offset by a decrease in potential morbidity and mortality from a treated IVM over the remaining life of the individual. Such discounting of the beneficial effects of surgical excision of IVMs in an effort to qualify the finding of surgery as an independent predictor of bad outcome and death is beyond the scope of this analysis. The data may, however, in part reflect the current heterogeneous center-specific management pattern of, specifically, BAVMs which remains a challenge and is subject to ongoing studies \[[@B12], [@B26]\]. Ongoing and future studies may and ought to give better insights to the rate and degree of recovery from invasive therapies in unbled patients in order to distinguish temporary from permanent functional deficits. It is, nevertheless, important to note that among patients admitted to US hospitals with the diagnoses of an IVM and ICrH, almost 1/10th will die and 2/5th will either die or be discharged to long-term health care facilities or home with home health care. Even more striking is the fact that among patients with the diagnosis of an IVM and without the presence of ICrH, only 1% will die, but still almost 1/6th will either die or be discharged with specialized medical care. Overall, 1/5th of all IVM-related admissions will either die or be discharged with long-term care.

4.3. Trend {#sec4.3}
----------

The comparison of our results with the US consensus data from 2000 suggests that IVMs are equally distributed among racial and ethnic groups and gender groups. It is interesting, however, that the average age increased from  48 ± 17  years to  50 ± 17  years over the study period (8 years). Assuming stable IVM detection rates \[[@B2]--[@B4]\] this could reflect general aging of the US population and mean that IVMs are now detected later in life. Perhaps, the overall improvement of vascular preventive management, such as treatment of hypertension, smoking cessation, and healthier life style, allows IVMs to remain undetected for a longer period of time. The decrease in the rate of ICrH may be an indicator for such improvements while the rates for seizure and headache remained relatively stable. However, the rate of cerebral ischemic events increased which might be an age and gender effect outweighing the effects of preventive measures. Also, more patients with IVMs present now in an emergent or urgent setting, that is, less electively. This may indicate that while IVMs remain longer silent, once they become symptomatic the clinical picture is relatively dramatic. The trend in the management of IVMs, however, is less invasive in diagnosis (less frequent cerebral angiograms) and therapy (less frequent surgery, but more endovascular therapy). However, radiation therapy also decreased over time. The latter might be due to the increasing shift of radiation therapy into the outpatient setting which is not part of the NIS.

The cost of inpatient IVM management in the US doubled over the 8 years from approximately \$200 million in years 2000/2001 to \$400 million in years 2006/2007. This is a true increase in cost as the cost-to-charge ratio remained stable at approximately 0.5. Additional factors significantly associated with charges include length of stay, number of procedures, and the main procedures, surgery, and endovascular therapy. In aggregate, the management of nonhemorrhagic patients (primary diagnosis only) accounted for 80% (\$1.7 billion) of the total charges over the study period. With an average of almost \$300 million of inpatient charges per year, the management of IVMs has economic significance in public health. Not included are costs from the outpatient setting and lost productivity \[[@B27]\].

4.4. Limitations {#sec4.4}
----------------

The main limitation is the fact that the ICD-9 coding system summarizes all IVMs into a single code. It is therefore difficult, if not impossible, to distinguish between IVM subtypes. To alleviate this limitation we performed further selections based on published epidemiological and clinical data (frequency, clinical presentation, and ICrH) and by focusing on the primary diagnostic code when analyzing presenting symptoms. In terms of the design, this study is primarily a cross-sectional study. The main disadvantage is that the results can provide only a "snapshot in time" of IVMs and its management. This design is not ideally suited for answering questions related to disease process or for revealing causal relationships between diseases. Second, our study also has characteristics of a case-control study, albeit unmatched, as we compare groups with and without hemorrhage and groups with and without surgery with each other. Other limitations include unidentifiable multiple admissions, incomplete clinical and anatomical data, for example, severity of symptoms, angioarchitecture, laboratory and imaging data, and unknown magnitude of misclassifications. Finally, because the NIS sample represents nationwide inpatient treatment, it may not reflect the true incidence or prevalence of IVMs in the general population.

However, there are also unique advantages of analyzing the NIS, a source with a large number of cases resulting in an impressive database with 6--8 million admissions per year and with its wealth of information. In addition, because of the representative nature of the NIS the "snapshot in time" becomes "the big picture" for USA hospital management of medical conditions which may give unique insides into rare diseases such as IVMs. NIS data is also well suited for hypothesis generation, especially with trend data, that certainly requires proof in well-designed prospective and longitudinal studies. The introduction of ICD-10 will allow better differentiation between the various IVM subtypes.

5. Conclusions {#sec5}
==============

IVMs are infrequent, equally prevalent among racial-ethnic, and gender groups and present in 1/6 patients with some form of ICrH. Overall, seizure is the dominant comorbid diagnosis (1/3 patients). IVMs are now increasingly detected later in life. The short-term outcome of IVM inpatient care has not markedly changed over almost a decade, resulting in death or discharge into specialized care in 1/5 patients.

All authors declare that they have no relevant conflicts of interest or financial interests to disclose. J. Pile-Spellman is member of the steering committee of the NIH-funded ARUBA trial.
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###### 

Univariate statistics.

  Year                                    2000/2001        2002/2003        2004/2005        2006/2007        *P*       Total
  --------------------------------------- ---------------- ---------------- ---------------- ---------------- --------- -----------------
  Total number of admissions              **73,605,206**   **76,024,680**   **77,825,620**   **78,992,164**             **306,447,670**
  Age, years (SD)                         48.3 (17.1)      47.8 (17.4)      49.2 (17.2)      50.1 (17.3)      \<0.001   48.9 (17.3)
  Women (%)                               51.5             51.8             51.7             54.2             \<0.001   52.4
  Admission type (%)                                                                                          \<0.001   
   Emergent                               42               39.7             49.5             51                         46
   Urgent                                 18.1             18.3             15.6             15.9                       16.9
   Elective                               39.9             41.8             34.5             32.8                       37
   Emergent and urgent                    60.1             58               65.1             66.9                       62.9
  Disposition (%)                                                                                             \<0.001   
   Routine                                74.7             77.5             74.1             72.8                       74.7
   Short-term hospital                    5                3.7              4.1              4.6                        4.4
   Another type facility                  13.4             11.2             11.9             13.4                       12.5
   Home health care                       4.7              4.9              6.3              6.5                        5.7
   Against medical advice                 0.3              0.6              1.1              0.8                        0.7
   Died                                   1.9              2                2.4              1.8              0.005     2
   Bad outcome\*                          20.3             18.7             21.7             22.5             \<0.001   20.9
  Length of stay, days                    5.9 (8.2)        5.4 (8.3)        5.4 (7.2)        5.4 (8.8)        \<0.001   5.5 (8.2)
  Number of diagnoses, any                4.9 (3.1)        5.2 (3.3)        5.9 (3.5)        6.8 (4.2)        \<0.001   5.8 (3.6)
  Number of procedures, any               2.0 (2.1)        1.9 (2.0)        1.8 (2.0)        2.0 (2.4)        \<0.001   2.0 (2.2)
  Race                                                                                                        \<0.001   
   White                                  69.0             67.9             69.6             64.3                       67.5
   Black                                  10.9             12.1             12.1             12.4                       11.9
   Hispanic                               11.9             13.0             12.0             15.6                       13.2
   Asian                                  4.7              3.3              3.0              3.4                        3.6
   Native American                        0.3              0.3              0.3              1.1                        0.5
   Other                                  3.1              3.3              3.0              3.2                        3.1
  Specific diagnosis all ranks                                                                                          
   Any ICrH                               17.5             14.0             14.8             13.7             \<0.001   14.9
   SAH                                    5                4.0              4.3              4.5              0.001     4.4
   ICH                                    11.9             9.2              9.5              8.4              \<0.001   9.7
   Other ICrH                             1.4              1.5              1.6              1.8              0.068     1.6
   Seizure                                33.8             32.5             30.0             31.1             \<0.001   31.8
   Headache                               7.1              7.8              10.1             11.7             \<0.001   9.3
   Acute ischemic stroke                  5.9              6.1              7.2              7.9              \<0.001   6.8
   TIA                                    2.1              2.1              2.7              3.1              \<0.001   2.5
  Primary specific diagnosis only         72.1             71.6             66.5             65.2             \<0.001   68.6
   Any ICrH                               12.6             9.3              11.4             9.4              \<0.001   10.6
   Seizure                                5.7              5.1              5.6              7.0              \<0.001   5.9
   Headache                               1.4              1.5              2.4              1.9              \<0.001   1.8
   Acute cerebral ischemia                2.4              2.4              3.5              4.1              \<0.001   3.1
   TIA                                    1.6              1.5              1.7              2.0              0.004     1.7
   IVM                                    48.4             51.8             41.9             40.8             \<0.001   45.5
  Intracranial ICA aneurysm, unruptured   2.5              2.7              2.8              2.7              0.305     2.7
  Procedures                                                                                                            
   Cerebral angiogram                     39.7             38.8             34.8             34.9             \<0.001   37.0
   Embolization                           ---^†^           15.5             17.4             18.4             \<0.001   13.4
   Surgery                                14.9             12.9             11.3             12.3             \<0.001   12.8
   Radiosurgery                           2.5              3.3              1.4              0.7              \<0.001   1.9
   Aneurysm clipping                      1.9              1.3              1.2              1.2              \<0.001   1.4
   Embolization, and surgery              0.1              1.2              1.6              2.5              \<0.001   1.4
   No procedure                           80.1             68.6             70.8             70.2             \<0.001   72.2
  Mechanical ventilation, all durations   5.4              4.8              5.8              5.9              \<0.001   5.5
   \<96 hours                             3.2              2.5              3.4              3.9              \<0.001   3.3
   ≥96 hours                              2.4              2.3              2.4              2.0              0.057     2.3

\*Death, another type facility, or home health care. **^†^**1%, misrepresentative figure, likely due to false or not coding. Standard deviation in parenthesis. Abbreviations: ICrH: intracranial hemorrhage, SAH: subarachnoid hemorrhage, ICH: intracerebral hemorrhage, TIA: transient ischemic attack, IVM: intracranial vascular malformation, ICA: internal carotid artery.

###### 

Risk of Death and Unfavorable Outcome\*.

                               Death   Unfavorable Outcome                                   
  ---------------------------- ------- --------------------- --------- ------ -------------- ---------
  Age                          1.02    (1.02--1.03)          \<0.001   1.04   (1.04-1.04)    \<0.001
  Elective admission           0.65    (0.47--0.90)          0.010     0.82   (0.75--0.90)   \<0.001
  Women                        1.16    (0.93--1.45)          0.191     1.11   (1.03--1.20)   0.005
  Length of stay               0.96    (0.95--0.97)          \<0.001   1.08   (1.07--1.08)   \<0.001
  Number of procedures         1.13    (1.07--1.19)          \<0.001   1.06   (1.03--1.08)   \<0.001
  White race                   1.07    (0.84--1.37)          0.585     0.99   (0.90--1.07)   0.738
  ICrH, any type               2.93    (2.27--3.80)          \<0.001   2.06   (1.85--2.30)   \<0.001
  Seizure                      1.33    (1.05--1.68)          0.020     1.59   (1.46--1.72)   \<0.001
  Headache                     0.25    (0.10--0.59)          0.002     0.70   (0.60--0.81)   \<0.001
  ICA aneurysm, unruptured     1.91    (1.08--3.40)          0.027     1.38   (1.09--1.74)   0.007
  Acute cerebral ischemia      0.98    (0.65--1.49)          0.942     1.55   (1.36--1.76)   \<0.001
  Cerebral angiography         0.27    (0.20--0.37)          \<0.001   0.62   (0.56--0.69)   \<0.001
  Embolization                 1.54    (1.00--2.35)          0.049     0.90   (0.77--1.04)   0.163
  Surgery                      1.04    (0.74--1.46)          0.834     1.38   (1.21--1.58)   \<0.001
  Radiosurgery                 0.00    ---                   0.994     0.50   (0.31--0.81)   0.005
  Aneurysm clipping            0.47    (0.18--1.20)          0.115     0.44   (0.31--0.62)   \<0.001
  Ventilation                  20.26   (15.01--27.34)        \<0.001   2.77   (2.37--3.25)   \<0.001
  Hospital bed size            1.13    (1.00--1.29)          0.057     1.07   (1.02--1.12)   0.002
  Hospital location/teaching   0.94    (0.81--1.09)          0.397     1.07   (1.01--1.12)   0.016

\*Goodness of fit model summary: Death (Nagelkerke *R*^2^ = 0.342), Unfavorable Outcome (Nagelkerke *R*^2^ = 0.281).

Abbreviations: 95%-CI: 95% Confidence Interval, ICrH: intracranial hemorrhage, ICA: internal carotid artery.

###### 

Univariate analyses: hemorrhage versus no hemorrhage and surgery versus no surgery.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *N* Group number                                Hemorrhage (*n* = 6,144)                                       No hemorrhage (*n* = 51,098)                     \              *P*\         \
                                                                                                                                                                  1 versus 2   1a versus 1b   2a versus 2b
  ----------------------------- ----------------- -------------------------- ----------------- ----------------- ------------------------------ ----------------- ------------ -------------- --------------
  Age                           50.7 (17.1)       51.7 (16.6)                50.6 (17.2)       48.9 (17.3)       41.6 (13.9)                    50.0 (17.5)       \<0.001      0.094          \<0.001

  Female (%)                    49.4              47.9                       49.6              52.8              53.8                           52.7              \<0.001      0.404          0.092

  Race (%)                                                                                                                                                        \<0.001      \<0.001        \<0.001

   White                        64.6              58.8                       65.3              68.2              64.9                           68.6                                          

   Black                        13.5              14.7                       13.4              11.6              8.4                            12.1                                          

   Hispanic                     13.8              13.9                       13.8              13.1              17.9                           12.4                                          

   Asian                        4.1               6.4                        3.8               3.5               4.4                            3.4                                           

   Native Americ                0.2               0                          0.3               0.6               0.6                            0.6                                           

   Other                        3.7               6.2                        3.4               3.1               3.8                            3                                             

  Admission (%)                                                                                                                                                   \<0.001      0.001          0.001

   Emergent                     66.7              60.5                       67.5              43.1              10.3                           47.1                                          

   Urgent                       24.4              28.4                       23.8              15.9              10.9                           16.5                                          

   Elective                     8.7               11.1                       8.3               40.8              78.8                           36.2                                          

   Emergent and Urgent          91.1              88.9                       99.6              59                21.2                           63.6                                          

  Number of diagnoses           6.7 (3.5)         7.5 (3.3)                  6.6 (3.5)         5.6 (3.6)         4.2 (2.9)                      5.8 (3.7)         \<0.001      \<0.001        \<0.001

  Number of procedures          3 (2.9)           5.5 (3.1)                  2.6 (2.7)         1.8 (1.9)         3.2 (2.3)                      1.6 (1.7)         \<0.001      \<0.001        \<0.001

  Diagnosis, any (%)                                                                                                                                                                          

   ICH                          65.4              71.1                       64.6              0                 0                              0                 \<0.001      \<0.001        

   SAH                          31.3              26.2                       32                0                 0                              0                 \<0.001      0.002          

   Other ICrH                   9.4               12.9                       8.9               0                 0                              0                 \<0.001      0.001          

   Acute Ischemia               4.5               4                          2.7               7.4               1.4                            8.3               \<0.001      0.053          \<0.001

   Seizure                      19.4              17                         19.7              33.7              33.4                           33.7              \<0.001      0.078          0.681

   Headache                     4.6               1.5                        5                 10                5.7                            10.6              \<0.001      \<0.001        \<0.001

   ICA aneurysm, unruptured     3.1               2.7                        3.1               2.6               2.4                            2.7               \<0.001      0.517          0.252

   Angiogram                    50.9              50.7                       50.9              34.7              45.9                           33.2              \<0.001      0.937          \<0.001

   Embolization                 7                 8.2                        6.9               14.3              11.6                           14.7              \<0.001      0.213          \<0.001

   Surgery                      12.1              ---                        ---               12.1              ---                            ---               0.099        ---            ---

   Radiosurgery                 0.1               0                          0.1               2.2               0.3                            2.5               \<0.001      0.405          \<0.001

   Aneurysm clipping            4.2               2.9                        4.4               1                 1.7                            0.9               \<0.001      0.065          \<0.001

   Ventilation, all durations   23.2              36.1                       21.4              2.7               4.9                            2.5               \<0.001      \<0.001        \<0.001

   Ventilation \>95 h           11                22.6                       9.3               0.9               2.4                            0.7               \<0.001      \<0.001        \<0.001

   Length of stay (*d*)         10.4 (12.9)       16.4 (11.5)                9.6 (12.9)        4.6 (5.8)         6.8 (6.4)                      4.3 (5.7)         \<0.001      \<0.001        \<0.001

  Outcome (%)                                                                                                                                                     \<0.001      \<0.001        \<0.001

   Routine discharge            44.4              31.5                       46.2              79.3              79.7                           79.3                                          

   Short-term hospital          12.4              3.9                        13.6              3.1               0.6                            3.4                                           

   Other type facility          27.6              45.6                       25.1              10.2              13.7                           9.8                                           

   Home health care             5.4               7.1                        5.2               5.7               4.7                            5.8                                           

   Death                        9.2               11.8                       8.9               0.9               1.1                            0.9                                           

   Unfavorable outcome          42.2              64.5                       39.2              16.8              19.5                           16.5                                          

   Charges mean (\$)            71,151 (90,787)   14,0034 (123,099)          61,256 (80,452)   35,792 (46,033)   77,846 (68,618)                30,090 (38,675)                \<0.001        \<0.001

   Charges sum (\$)             414.8 Mill        102.6 Mill                 312.3 Mill        1,717.4 Mill      539 Mill                       1,380 Mill                                    

  Hospital Characteristics                                                                                                                                                                    

  Bed Size                                                                                                                                                        0.01         \<0.001        0.006

   Small                        39.4              40.3                       39.3              40.1              40.4                           40.1                                          

   Medium                       26.2              32.4                       25.4              28                26.1                           28.2                                          

   Large                        34.3              27.4                       35.3              31.9              33.6                           31.7                                          

  Location/Teaching                                                                                                                                               0.265        \<0.001        0.001

   Rural                        43.6              51.8                       42.5              42.4              43.4                           42.2                                          

   Urban Non-Teaching           40.1              29.1                       41.7              40.9              41.8                           40.7                                          

   Urban Teaching               16.3              19.1                       15.9              16.7              14.8                           17                                            

  Hospital Region                                                                                                                                                 0.088        \<0.001        \<0.001

   NE                           18.2              18.5                       18.2              19.4              14.7                           20.1                                          

   NW/NC                        22                21.3                       22.1              22.4              16                             23.3                                          

   S                            33.9              27.6                       34.8              33.9              33.1                           34                                            

   W                            25.8              32.7                       24.9              24.3              36.2                           22.7                                          
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Standard deviation in parenthesis.

Abbreviations: ICrH: intracranial hemorrhage, SAH: subarachnoid hemorrhage, ICA: internal carotid artery.

###### 

Determinants of hospital charges.

###### 

\(a\)

                               Model 1     Model 2                                                                            
  ---------------------------- ----------- --------- --------- ---------- --------- ----------- --------- -------- ---------- ---------
  Age (y)                      61.48       11.49     0.0200    5.3514     0.00000                                             
  Elective admission           1763.74     424.92    0.0160    4.1508     0.00003                                             
  In-hospital death            12044.56    1339.92   0.0317    8.9890     0.00000                                             
  Women                        −669.94     351.65    −0.0063   −1.9052    0.05677                                             
  Length of stay (*d*)         3613.12     28.99     0.5026    124.6288   0.00000   3412.81     22.53     0.4535   151.5009   0.00000
  \# Diagnoses                 −287.82     61.42     −0.0199   −4.6863    0.00000                                             
  \# Procedures                7049.92     118.25    0.2800    59.6181    0.00000   8824.37     92.78     0.3215   95.1101    0.00000
  Time (year)                  6169.46     232.79    0.0888    26.5024    0.00000   5677.02     137.73    0.1095   41.2199    0.00000
  Median income                847.15      156.29    0.0177    5.4205     0.00000                                             
  ICrH                         2804.75     931.44    0.0182    3.0112     0.00260                                             
  ICA aneurysm, unruptured     1300.84     1135.07   0.0039    1.1460     0.25179                                             
  Acute ischemia               530.73      693.29    0.0026    0.7655     0.44397                                             
  Seizure                      −60.35      414.97    −0.0005   −0.1454    0.88438                                             
  Headache                     1414.91     636.16    0.0082    2.2241     0.02615                                             
  Angiography                  1372.53     431.61    0.0124    3.1800     0.00147                                             
  Embolization                 29192.74    534.78    0.2086    54.5888    0.00000   29502.47    473.73    0.1707   62.2773    0.00000
  IVM surgery                  26550.75    608.40    0.1564    43.6403    0.00000   27449.01    488.44    0.1553   56.1973    0.00000
  Radiosurgery                 27182.37    1354.84   0.0682    20.0632    0.00000   16798.46    1122.82   0.0397   14.9609    0.00000
  Aneurysm clip                27896.46    1678.19   0.0573    16.6230    0.00000   17164.04    1341.84   0.0338   12.7914    0.00000
  Ventilation                  12209.90    933.97    0.0518    13.0731    0.00000                                             
  ICrH primary diagn.          3325.46     1054.94   0.0187    3.1523     0.00162                                             
  Seizure primary diagnosis    1473.41     787.55    0.0068    1.8709     0.06137                                             
  Headache primary diagnosis   921.68      1334.31   0.0025    0.6908     0.48972                                             
  Constant                     −26640.78   1063.46             −25.0510   0.00000   −17986.64   416.53             −43.1820   0.00000

###### 

\(b\)

            Adjusted *R* square   df1   df2     Sig. *F* Change   Durbin-Watson
  --------- --------------------- ----- ------- ----------------- ---------------
  Model 1   0.6648                23    31610   0.0000            0.3258
  Model 2   0.6161                8     56205   0.0000            0.3172

Abbreviations: Unstd.: unstandardized, Std.: standardized, \#: number of, ICrH: intracranial hemorrhage, ICA: internal carotid artery, IVM: intracranial vascular malformation.

[^1]: Academic Editor: Graham S. Venables
